Genflow Biosciences PlcGenflow Biosciences PlcGenflow Biosciences Plc

Genflow Biosciences Plc

No trades
No trades

Compare with Genflow Biosciences Plc


Market capitalization
‪14.80 M‬USD
−0.0044USD
‪−1.91 M‬USD
0.00USD
‪364.47 M‬
Beta (1Y)
−1.35

Profile


CEO
Eric Jean Marie Leire
Headquarters
London
Founded
2020
IPO date
Jan 17, 2022
ISIN
GB00BP2C3V08
FIGI
BBG01GZH7LS3
Identifiers
ISIN GB00BP2C3V08
CFI code
ESVUFR
Genflow Biosciences Plc operates as a biotechnology company, which engages in the research and development of gene therapies to counteract the effects of aging and diseases associated with advanced age. The company was founded by Eric Leire in 2020 and is headquartered in London, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of GENFF is 0.0545 USD — it has increased by 0.55% in the past 24 hours. Watch Genflow Biosciences Plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Genflow Biosciences Plc stocks are traded under the ticker GENFF.
GENFF stock has risen by 9.00% compared to the previous week, the month change is a 37.16% rise, over the last year Genflow Biosciences Plc has showed a 445.00% increase.
GENFF reached its all-time high on May 5, 2026 with the price of 0.0711 USD, and its all-time low was 0.0100 USD and was reached on Jul 9, 2025. View more price dynamics on GENFF chart.
See other stocks reaching their highest and lowest prices.
GENFF stock is 0.55% volatile and has beta coefficient of −1.35. Track Genflow Biosciences Plc stock price on the chart and check out the list of the most volatile stocks — is Genflow Biosciences Plc there?
Today Genflow Biosciences Plc has the market capitalization of ‪14.80 M‬, it has increased by 4.19% over the last week.
Yes, you can track Genflow Biosciences Plc financials in yearly and quarterly reports right on TradingView.
GENFF net income for the last half-year is ‪−916.02 K‬ USD, while the previous report showed ‪−1.01 M‬ USD of net income which accounts for 0.00% change. Track more Genflow Biosciences Plc financial stats to get the full picture.
No, GENFF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GENFF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Genflow Biosciences Plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Genflow Biosciences Plc technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Genflow Biosciences Plc stock shows the strong buy signal. See more of Genflow Biosciences Plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.